Curbing Drug-Related Halitosis for Closer Moments
Overview
This report highlights the prevalence and causes of drug-related halitosis, emphasizing the need for awareness and management strategies among affected individuals. The study identifies specific medications that contribute to both intra-oral and extra-oral halitosis, providing a framework for clinicians to address this condition effectively.
Background
Halitosis, or bad breath, is a common condition that can significantly impact an individual's social and emotional well-being. It can arise from various sources, including certain medications that induce xerostomia or medication-related osteonecrosis of the jaw. Understanding the relationship between drug use and halitosis is crucial for healthcare providers to offer appropriate management and improve patients' quality of life.
Data Highlights
No numerical data or trial results were provided in the source material.
Key Findings
- Halitosis can be classified into intra-oral and extra-oral types, with varying causes.
- Drugs causing xerostomia, such as anticholinergics and certain antidepressants, are linked to intra-oral halitosis.
- Extra-oral halitosis can result from medications like ranitidine, cysteamine, and antifungals.
- Medication-related osteonecrosis of the jaw (MRONJ) is a significant contributor to intra-oral malodor.
- Dental evaluations can help identify and manage intra-oral sources of halitosis effectively.
- Prior knowledge of medications that induce halitosis can aid clinicians in diagnosis and management.
Clinical Implications
Clinicians should conduct thorough medication reviews to identify potential contributors to halitosis in their patients. Effective management strategies may include improving oral hygiene, treating underlying dental issues, and recommending hydration and saliva substitutes for those experiencing xerostomia.
Conclusion
Highlight the need for further research on mechanisms of drug-related halitosis.
References
- Iranitalab M, Ouanounou A, International Dental Journal, 2023 -- Curbing Drug-Related Halitosis for Closer Moments
- compendium — Problem-Solving
- inside dentistry — Modern Solutions for Biofilm Management and Fluoride-Free Remineralization
- ADA News — Half of dentists surveyed report patients high during dental visits
- conexiant — Medical Oddities: Chew on This Cancer Prevention Idea
- Halitosis - Dental Disorders - Merck Manual Professional Edition
- Half of dentists surveyed report patients high during dental visits
- Modern Solutions for Biofilm Management and Fluoride-Free Remineralization
- Problem-Solving
- Effects of 0.05% Cetylpyridinium Chloride Mouthwash on Halitosis and Tongue Microbiota in Patients Undergoing Orthodontic Treatment: A Double-Blind Randomized Clinical Trial | MDPI
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
